Funded PhD scholarship to develop new nanomedicines from chronic lung diseases
Chronic lung diseases are responsible for millions of premature deaths each year and there an urgent medical need to develop new and effective treatments. We are developing new nanomedicines to deliver therapies to a specialized immune cell in the lungs called macrophages. Using a multidisciplinary approach, we will develop innovative treatments to improve health outcomes.
RMIT funded scholarship provides a stipend of $33,826 per annum (pro-rata) for 3 years.
Standard RMIT PhD enrolment requirement. Open to Domestic and International Students.
All applicants should email the following to Prof. Steven Bozinovski via email@example.com:
Preferable background and/or previous experience or publications in immunology, pharmacology, materials science and/or nanotechnology. Experience or strong interest in respiratory science and health.
Acknowledgement of Country
RMIT University acknowledges the people of the Woi wurrung and Boon wurrung language groups of the eastern Kulin Nation on whose unceded lands we conduct the business of the University. RMIT University respectfully acknowledges their Ancestors and Elders, past and present. RMIT also acknowledges the Traditional Custodians and their Ancestors of the lands and waters across Australia where we conduct our business - Artwork 'Luwaytini' by Mark Cleaver, Palawa.